Skip to content

A study focused at identifying disrupted biological factors and patient-tailored interventions for adolescents with Q-Fever Fatigue Syndrome

A study focused at identifying disrupted biological factors and patient-tailored interventions for adolescents with Q-Fever Fatigue Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24476
Enrollment
60
Registered
2020-07-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q-fever fatigue syndrome (QFS), Juvenile Idiopathic Arthritis (JIA) and Chronic Fatigue Syndrome (CFS/ME).

Interventions

1) Patient-tailored PROfeel lifestyle advices 2) Generic dietary advice

Sponsors

UMC Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All subjects must meet the following criteria: • Age of 12-25 years old • Able to speak, read, understand and write Dutch Inclusion criteria for QFS-patients: • (Suspected) diagnosis with QFS according to the Dutch Guidelines. • Fatigue lasting for at least 6 months. • Debilitating fatigue, with detrimental effects on daily functioning (work and/or private situation). • Seropositive for C. Burnetii. • No diagnoses of chronic Q-fever, recent diagnostics (39 Inclusion criteria for CFS/ME patients: • (Suspected) CFS/ME diagnosis according to the CDC criteria. • No diagnosis of QFS. • Fatigue severity subscale (CIS8) score >39. Inclusion criteria for JIA patients: • Diagnosed with JIA, at least 3 months on stable medication and a stable disease activity score (JADAS-criteria). • No diagnosis of QFS. • Expressing fatigue as a major complaint and CIS8 score >34 (mean +1SD). • Being fatigued for at least 3 months.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Diagnosis of chronic Q-fever and active disease. • Cognitive impairment, estimated IQ<70. • Concomitant diagnoses that may explain the fatigue. • Any current and predominated psychiatric comorbidity with could explain fatigue (i.e. major depression disorder, presence of suicidal risk). • Owns no smartphone.

Design outcomes

Primary

MeasureTime frame
Fatigue severity

Secondary

MeasureTime frame
Self-efficacy and quality of life

Contacts

Public ContactAnouk Vroegindeweij

UMC Utrecht

a.vroegindeweij@umcutrecht.nl+31 6 5017 75 78

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)